NAD affirms Allegra claims; asks Chattem to quantify ‘fast-acting’
NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Tuesday determined Chattem, maker of the Allegra allergy relief medication, provided a reasonable basis for the claim that “only Allegra combines fast, non-drowsy, 24-hour relief.”
However, the NAD recommended that the advertiser modify the claim to make clear that the onset of action for Allegra is one hour, and recommended Chattem discontinue advertising that suggested the product provided immediate relief. As part of a separate, prior decision, the NAD had ruled that McNeil Consumer Healthcare’s Zyrtec had an onset of action of one hour, while Claritin had an onset of action of three hours. “Given that there is sufficient data providing a reasonable basis for a finding that Zyrtec and Allegra have the same onset of action time — one hour — simply put, Claritin is not as fast as Allegra,” NAD noted.
The NAD further recommended that the advertiser modify any future product packaging mock-ups in print advertisements to clearly and conspicuously disclose what is meant by “fast” — that the product starts working in one hour.
The Allegra claims originally were challenged by Schering-Plough Healthcare Products, maker of Claritin.
Navarro Discount Pharmacy aims to help parents save money this back-to-school season
MIAMI — Navarro Discount Pharmacy, a 29-store Hispanic-owned pharmacy chain and an MBF Healthcare portfolio company, has announced that it is supporting back to school for parents with activities that include cash donations to Miami-Dade County Public Schools and free backpacks filled with school supplies.
“The goals of this year’s back-to-school promotion are to save busy parents time and money, prepare them early for the start of the school year and help out their schools at the same time,” stated Cristy Leon-Rivero, VP marketing for Navarro Discount Pharmacy. "We are committed to supporting education and creating a convenient shopping experience for parents.”
Navarro’s back-to-school activities include:
- Donating 5% of the sales it generates on all back-to-school purchases to Miami-Dade County Public Schools. When checking out at the register, parents tell the cashier the name of the Miami-Dade County Public School and the donation will be sent directly to the school;
- Partnering with Coca-Cola, who also will donate 5% of its purchases back to the school of choice;
- Offering in-store school physicals and vaccines in conjunction with Miami Children’s Hospital; and
- Donating 1,000 backpacks filled with school supplies to nonprofit groups — Amigos for Kids, Kiwanis and the Centro Mater Foundation — and to the City of North Miami.
Other local partners involved include SpendforED, a local nonprofit dedicated to supporting public education that links schools with businesses and the local community, providing them with financial resources. SpendforED’s EDBUCK coupons can be redeemed at any Navarro store location. SpendforED is a supporter of Miami Dade County Public School’s Foundation for New Education Initiatives.
Perrigo sales, profits increase in fiscal 2011
ALLEGAN, Mich. — Generic drug maker Perrigo reported sales of $2.76 billion and profits of $341 million in fiscal year 2011, according to an earnings report released Tuesday.
The company’s sales represent a 21% increase over fiscal year 2010, while its profits represent a 52% increase. Much of the increase in sales came from the acquisition of PBM Holdings and Orion Labs, as well as $192 million in new product sales.
For fourth quarter 2011, which ended June 25, sales were $705 million, a 14% increase over fourth quarter 2010, while profits were $86 million, compared with $49 million a year ago.
Prescription drugs had sales of $92 million, a 12% increase over fourth quarter 2010’s $83 million. OTC drugs had sales of $434 million, compared with $399 million last year; nutritionals had sales of $123 million, compared with $84 million last year; and active pharmaceutical ingredient sales decreased from $39 million to $37 million during the same period.